Forecasting drug utilization and expenditure: ten years of experience in Stockholm

by Love Linnér, Irene Eriksson, Marie Persson, Björn Wettermark
Published 2020-05-01

Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study

by Erica M. Brostedt, Mussie Msghina, Marie Persson, Björn Wettermark
Published 2017-12-01

Drug–disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension – a population-based registry study

by Katharina Schmidt-Mende, Morten Andersen, Björn Wettermark, Jan Hasselström
Published 2020-07-01

Trends in coronary heart disease mortality and statin utilization in two European areas with different population risk levels: Stockholm and Sicily

by Federico Vancheri, Björn Wettermark, Lars-Erik Strender, Lars G Backlund
Published 2014-01-01

Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care

by Tomas Forslund, Pauline Raaschou, Paul Hjemdahl, Ingvar Krakau, Björn Wettermark
Published 2011-01-01

Trends in medicines procurement by the Brazilian federal government from 2006 to 2013.

by Tatiana Chama Borges Luz, Claudia Garcia Serpa Osorio-de-Castro, Rachel Magarinos-Torres, Bjorn Wettermark
Published 2017-01-01

A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic

by Tamás Ágh, Job FM van Boven, Björn Wettermark, Björn Wettermark, Enrica Menditto, Hilary Pinnock, Ioanna Tsiligianni, Guenka Petrova, Ines Potočnjak, Fatjona Kamberi, Przemyslaw Kardas, European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE)
Published 2021-06-01

Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak

by Przemyslaw Kardas, Job Frank Martien van Boven, Hilary Pinnock, Enrica Menditto, Björn Wettermark, Ioanna Tsiligianni, Tamás Ágh
Published 2021-05-01

The Early Awareness and Alert System in Sweden: History and Current Status

by Irene Eriksson, Irene Eriksson, Björn Wettermark, Björn Wettermark, Marie Persson, Morgan Edström, Brian Godman, Brian Godman, Brian Godman, Anna Lindhé, Rickard E. Malmström, Rickard E. Malmström, Helena Ramström, Mia von Euler, Mia von Euler, Mia von Euler, Anna Bergkvist Christensen
Published 2017-10-01

Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.

by Elisabetta Poluzzi, Emanuel Raschi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba, Bjorn Wettermark, Miriam Sturkenboom, Fabrizio De Ponti
Published 2015-01-01

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.

by Emanuel Raschi, Elisabetta Poluzzi, Brian Godman, Ariola Koci, Ugo Moretti, Marija Kalaba, Marion Bennie, Corrado Barbui, Bjorn Wettermark, Miriam Sturkenboom, Fabrizio De Ponti
Published 2013-01-01

Societal impact for patients with psoriasis: A nationwide Swedish register studyCapsule Summary

by Henrike Häbel, PhD, Björn Wettermark, PhD, David Hägg, PhD, Reginald Villacorta, PhD, E.Christina M. Wennerström, PhD, Marie Linder, PhD
Published 2021-06-01

Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

by F. Cankat Tulunay, Kamila Wendykowska, Inês Teixeira, Catherine Sermet, Ulrich Schwabe, Roberta Joppi, Ott Laius, Marija Kalaba, Kristina Garuolienè, Thomas Burkhardt, Morten Andersen, Iain Bishop, Bjorn Wettermark, William Shrank, Brian Godman, Corinne Zara, Lars L Gustafsson
Published 2010-08-01

The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.

by Isabela Maia Diniz, Augusto Afonso Guerra, Livia Lovato Pires de Lemos, Kathiaja M Souza, Brian Godman, Marion Bennie, Björn Wettermark, Francisco de Assis Acurcio, Juliana Alvares, Eli Iola Gurgel Andrade, Mariangela Leal Cherchiglia, Vânia Eloisa de Araújo
Published 2018-01-01

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

by Brian Godman, Brian Godman, Brian Godman, Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Antony P. Martin, Steven Simoens, Amanj Kurdi, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso Guerra, Augusto Alfonso Guerra, Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Björn Wettermark, Zinhle Matsebula, Stephen Campbell, Stephen Campbell, Alan Haycox
Published 2018-12-01